Benjamin F. Edwards & Company’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $6K | Hold |
1,130
| – | – | ﹤0.01% | 1821 |
|
|
2024
Q1 | $6K | Hold |
1,130
| – | – | ﹤0.01% | 1804 |
|
|
2023
Q4 | $10K | Hold |
1,130
| – | – | ﹤0.01% | 1647 |
|
|
2023
Q3 | $9K | Hold |
1,130
| – | – | ﹤0.01% | 1407 |
|
|
2023
Q2 | $11K | Hold |
1,130
| – | – | ﹤0.01% | 1384 |
|
|
2023
Q1 | $12K | Hold |
1,130
| – | – | ﹤0.01% | 1367 |
|
|
2022
Q4 | $5K | Sell |
1,130
-15,000
| -93% | -$66.4K | ﹤0.01% | 1553 |
|
|
2022
Q3 | $121K | Buy |
16,130
+5,000
| +45% | +$37.5K | 0.01% | 807 |
|
|
2022
Q2 | $112K | Hold |
11,130
| – | – | 0.01% | 826 |
|
|
2022
Q1 | $138K | Hold |
11,130
| – | – | 0.01% | 781 |
|
|
2021
Q4 | $255K | Hold |
11,130
| – | – | 0.01% | 618 |
|
|
2021
Q3 | $246K | Hold |
11,130
| – | – | 0.01% | 607 |
|
|
2021
Q2 | $144K | Buy |
11,130
+2,000
| +22% | +$25.9K | 0.01% | 740 |
|
|
2021
Q1 | $119K | Sell |
9,130
-2,000
| -18% | -$26.1K | 0.01% | 796 |
|
|
2020
Q4 | $154K | Buy |
11,130
+1,130
| +11% | +$15.6K | 0.01% | 709 |
|
|
2020
Q3 | $147K | Hold |
10,000
| – | – | 0.01% | 664 |
|
|
2020
Q2 | $163K | Hold |
10,000
| – | – | 0.01% | 615 |
|
|
2020
Q1 | $145K | Hold |
10,000
| – | – | 0.01% | 586 |
|
|
2019
Q4 | $203K | Hold |
10,000
| – | – | 0.01% | 590 |
|
|
2019
Q3 | $53K | Buy |
10,000
+3,000
| +43% | +$15.9K | ﹤0.01% | 911 |
|
|
2019
Q2 | $46K | Buy |
7,000
+5,000
| +250% | +$32.9K | ﹤0.01% | 927 |
|
|
2019
Q1 | $13K | Hold |
2,000
| – | – | ﹤0.01% | 1247 |
|
|
2018
Q4 | $14K | Hold |
2,000
| – | – | ﹤0.01% | 1175 |
|
|
2018
Q3 | $13K | Hold |
2,000
| – | – | ﹤0.01% | 1208 |
|
|
2018
Q2 | $11K | Buy |
+2,000
| New | +$11K | ﹤0.01% | 1241 |
|